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Abstract
Recently, development of fluorescent nanoparticle-based probes for various bioimaging
applications has attracted great attention. This work aims to develop a new type fluorescent
nanoparticle conjugate and evaluate its cytotoxic effects on A549 and BEAS 2B cell lines.
Throughout the study, ionically crosslinked chitosan nanoparticles (CNs) were conjugated with
carboxylated 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY-COOH). The results of conju-
gates (BODIPY-CNs) were investigated with regard to their physic-chemical, optical, cytotoxic
properties and cellular internalization. The morphology of BODIPY-CNs was found to be
spherical in shape and quite uniform having average diameter of 70.25 ± 11.99 nm. Cytotoxicty
studies indicated that although BODIPY-COOH itself was quite toxic on both A549- and BEAS
2B-treated cells, CNs increased the cell viability of both cell lines via conjugation to BODIPY-
COOH fluorescent molecule up to 67% for A549 and 74% for BEAS 2B cells. These results may
suggest a possible utilization of the new fluorescent nanoparticle-based probe for bioimaging
in biology and medicine.
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Introduction
In recent years, bioimaging applications with fluorescent
probes have attracted important attention in biology and
medicine (Chekina et al., 2011; Corr et al., 2008; Terai &
Nagano, 2008; Yuan et al., 2013). Especially, bioimaging
applications with fluorescent molecules on cancer cells are
highly promising with the possibility of real-time visual
detection of an analyte both in solution and living organism
(Chan et al., 2012).
Organic fluorescent dyes have been greatly applied in the
synthesis of fluorescent probes for molecular imaging and
biomedical diagnosis (Kobayashi et al., 2010). Boron-
dipyrromethene (BODIPY), a type of organic fluorescent
molecules, has remarkable photophysical properties such as
long excitation/emission wavelengths, high molar absorption
coefficients and fluorescence quantum yield (Boens et al.,
2012; Ulrich et al., 2008; Loudet & Burgess, 2007). Thus, the
BODIPY fluorophore can be a good candidate to be utilized
as the organic fluorescent molecules for bioimaging applica-
tions (Bernhard et al., 2010). On the other hand, organic dyes
are not very stable due to photobleaching problem, low-signal
intensities and wide fluorescent spectrum limitations. It has
lately been reported that, conjugation of organic dyes with
polymer-based nanoparticles has increased their stability
compared to common single organic fluorophores (Nune
et al., 2009).
Chitosan nanoparticles have attracted a remarkable atten-
tion lately. As a potential biomedical material, chitosan, a
poly-N-acetyl glucosamine, is the N-deacetylated product of
chitin (major component of crustacean shells), which is the
second most abundant biopolymer after cellulose (Kumar
et al., 2004). Chitosan, a type of cationic polysaccharide, has
many significant biological and chemical properties due to a
unique set of characteristics that include biocompatibility,
biodegradability, nontoxicity, physiological inertness and
antibacterial properties (Rinaudo, 2006). Therefore, chitosan
can be used for nano-sized materials in biomedicine for
variety applications (Jayakumar et al., 2010). Chitosan as
nanoparticles are reported to be a suitable polymer-based
material for loading organic fluorophores because of their
high labeling affinity to various biomolecules (Zhao & Wu,
2006).
Although, many studies have been conducted for the
development of chitosan nanoparticles with variety of fluor-
escent probes for the purpose of bioimaging applications,
studies of BODIPY conjugated chitosan nanoparticles have
not been reported. The objective of this study is to obtain
BODIPY-conjugated chitosan nanoparticles as fluorescent
probe and evaluate their cytotoxic effect on A549 and BEAS
2B cell lines. In the development of a functional fluorescent
nano-size probe, initially, CNs were prepared based on ionic
gelation method and BODIPY-COOH fluorescent dye was
synthesized as a type of organic fluorescent molecule. CNs
were then conjugated with BODIPY-COOH and the
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conjugation was confirmed by visualizing the newly formed
compound under UV light and confocal microscope. The
physicochemical properties of the CNs and BODIPY-COOH
conjugated CNs were determined by several methods
including Scanning Electron Microscopy (SEM), Fourier
Transform Infrared Spectroscopy (FT-IR), Dynamic Light
Scattering (DLS), Atomic Force Microscopy (AFM).
Cytotoxic effects of CNs, BODIPY-COOH and BODIPY-
CNs were evaluated comparing cell viability of A549 and
BEAS 2B cell lines. According to our results, a newly formed
fluorescent nanoparticle-based probe could be a good candi-
date for potential bioimaging applications in biology and
medicine.
Materials and methods
Materials
Chitosan (190–310 kDa and degree of acetylation 75–85%),
tripolyphosphate sodium (TPP), 3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenylterazolium bromide (MTT) and 40,6-diamidino-
2-phenylindole (DAPI) were obtained from Sigma-Aldrich
(St. Louis, MO). All the other chemicals were obtained from
local chemical suppliers.
Synthesis of BODIPY-COOH
Carboxylated 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
(BODIPY-COOH) was synthesized by the method of Brizet
et al. (2013) with some modification. In the procedure, to an
anhydrous dichloromethane (DCM) (50 mL) of 2,4-dimethy-
lethylpyrrole (DMAP) (739.2 mg, 6.0 mmol), 4-carboxy-ben-
zaldehyde (450.4 mg, 3.0 mmol) and catalytic amount of
trifluoroacetic acid (2–3 drops) were added. The reaction
mixture was stirred at room temperature for 24 h. A solution
of p-chloranil (1.475 g, 6.0 mmol) in dichloromethane
(10 mL) was added and the mixture was stirred for 1 h.
Triethylamine (6 mL, 45 mmol) and BF3.Et2O (6 mL,
47.4 mmol) were added successively. The purple solution
was stirred 4 h. The reaction mixture was extracted with
dichloromethane (3 100 mL), dried over sodium sulfate and
concentrated under vacuum. The residue was purified by
silica gel column chromatography (Hex:EtAc 4:1). The
resulting solid was further purified by recrystallization
(chloroform-hexane system) to give title product as a red
solid (Yield: 35%, m¼ 445 mg). 1H NMR (400 MHz,
CDCl3):  8.26 (d, J¼ 8.4 Hz, 2H), 7.46 (d, J¼ 7.4 Hz, 2H),
2.54 (s, 6H), 2.31 (q, J¼ 7.6 Hz, 4H), 1.28 (s, 6H), 0.99
(t, J¼ 7.6 Hz, 6H). 13C NMR (100 MHz, CDCl3):  171.0,
154.4, 141.7, 138.4, 138.0, 133.1, 130.8, 130.2, 129.7, 128.9,
17.1, 14.6, 12.6, 11.8.
Preparation of chitosan nanoparticles (CNs)
Chitosan nanoparticles (CNs) were synthesized by following
the Calvo’s ionic gelation procedure (Calvo et al., 1997).
According to this procedure, tripolyphosphate (TPP) was used
as a crosslinker with chitosan. Chitosan was dissolved in 1% (w/
v) acetic acid solution. Then, the pH of the solutionwas adjusted
to 5.0 with 3.0 M NaOH solution. The aqueous solution of TPP
was obtained as 0.1% in acetic acid solution. Chitosan
nanoparticles started to form spontaneously upon addition of
TPP into the solution of chitosan under magnetic stirring drop
wise at room temperature. After one hour of mixing chitosan
with TPP, the solution was centrifuged (13500 rpm/30 min) and
the pellet was freeze-dried by lyophilization.
Preparation and characterization of BODIPY-CNs
For preparation of BODIPY-CNs, freeze-dried chitosan
nanoparticles were added to 5 ml of DMSO under constant
magnetic stirrer. To this solution, BODIPY-COOH solution
[5 mg in 1 mL DMSO and preactivated with 0.5 mg EDC
(1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide reagent in
1 mL of pH 5.0 NaP buffer] was added drop wise. The
reaction between CNs and BODIPY-COOH was allowed to
continue for 24 h on the magnetic stirrer at room temperature.
BODIPY-CNs were then centrifuged at 13 500 rpm for
30 min and washed with DMSO several times until the
free BODIPY-COOH was not left in the supernatant. The
BODIPY-COOH concentration was measured by UV-visible
Spectrophotometry (Shimadzu-UV 2540, Kyoto, Japan)
calibrated with standard solutions containing 0.005–0.5 mg/
mL of BODIPY-COOH dissolved in DMSO. Binding effi-
ciency (w/w %) of the conjugate was calculated at the
maximum wavelength of 510 nm.
The measurement of particle size (Z-average) of nanopar-
ticles were performed on a Zetasizer Nano-ZS (Malvern
Zetasizer, 3000 HSA, Worcestershire, UK) on the basis of
dynamic light scattering (DLS) techniques. The measure-
ments were performed in triplicates at a temperature of 25 C
and the samples were diluted with distilled water and
measured at scattering angle of 173. Changes in functional
groups of chitosan nanoparticle after being conjugated with
BODIPY-COOH were characterized by FT-IR (Perkin Elmer
Spectrum 100, Waltham, MA) according to the potassium
bromide pellet method on a Tensor-27 (Bruker, Billerica,
MA) in the range of 800–4000 cm1. Visualization of the
morphology of the particles was performed by Atomic Force
Microscope on tapping mode (Digital Instruments
Nanoscope, Santa Barbara, CA) and Scanning Electron
Microscope (SEM, FEI QUANTA 250 FEG, Hillsboro, OR).
The optical property of BODIPY-CNPs was determined by
recording the fluorescence emission spectra using excitation
at the range of 400–500 nm with a fluorescence spectropho-
tometer (Perkin Elmer).
Cell culture
BEAS 2B (human bronchial epithelial cell line) and A549
(adenocarcinoma human alveolar basal epithelial cells) cells
lines were provided by the Biotechnology and Bioengineering
Research and Application Center, IZTECH. The cells were
grown in Roswell Park Memorial Institute-1640 (RPMI-1640)
growth medium containing 10% fetal bovine serum (FBS) and
1% gentamicin sulfate in a humidified atmosphere containing
5% CO2 at 37
C. Typically, cells were passaged through
trypsinization and in growth medium.
In vitro cellular uptake of BODIPY-CNs
For the visualization of cells treated with BODIPY-CNs and
BODIPY-COOH, confocal microscopy (Olympus-CKX41,
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Tokyo, Japan) was used for A549 cell lines. The cells of
passage 14 were seeded on Lab-Tek chambered cover
glasses (Thermo Scientific, Waltham, MA) at a density of
1 104 cells/cm2 and incubated overnight at 37 C, 5% CO2
and 95% relative humidity. Then, the cells were treated with
0.2 mg/mL BODIPY-COOH and BODIPY-CNs in 20 mL of
transport medium for 4 h. The cells were washed twice with
phosphate-buffered saline (PBS), fixed in 3.7% paraformal-
dehyde and stained with DAPI (40,6-diamidino-2-phenylin-
dole) before imaging. The applied excitation and emission
wavelengths of DAPI dye in this study were 350 and 470 nm,
respectively. The excitation and emission wavelengths used
here for BODIPY-COOH and BODIPY-CNs were 532 and
640 nm, respectively.
Cell viability assays
MTT assay was performed to evaluate the cell viability of
A549 and BEAS 2B cell lines. Cells were seeded on 96-well
micro assay plates at a density of 1 104 cells/cm2 and
incubated at 37 C in 95% airs, 5% CO2 environments for
24 h. BODIPY-CNs were added and incubated for 24 h, 48 h
and 72 h. After incubation, the medium was removed and
replaced with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) – containing medium. Plates were
incubated for an additional 4 h at 37 C. MTT medium was
removed and 100 ml of DMSO was added to dissolve the
formazan crystal. The absorbance was determined using plate
reader at a wavelength of 540 nm. Metabolic activity at
standard growth conditions was considered 100%. The
concentration inhibiting cell viability by 50% (IC50 values)
was calculated.
Figure 2. AFM images of (A) CNs at 700 nm, (B) CNs at 230 nm, (C) BODIPY-CNs at 700 nm, (D) BODIPY-CNs at 230 nm scale.
Figure 1. The size distribution by intensity of CNs and BODIPY-CNs.
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Statistical analysis
The results represented the mean ± standard deviation from at
least three independent experiments. Statistical significance
was assessed by One-way ANOVA using GraphPad Prism5,
and with the Dunnett’s multiple comparison test.
Results and discussion
Preparation and characterization of Ns
Ionic gelation is the convenient method for the fabrication of
the chitosan nanoparticles because the process is simple,
requires mild conditions and avoids the use of organic
solvents and high temperatures (Berger et al., 2004; Nasti
et al., 2009). Therefore, in this study, chitosan nanoparticles
were synthesized by complexation of polyanionic TPP and
cationic chitosan using ionic gelation method at room
temperature. The respective average diameters, measured by
Zetasizer, of chitosan nanoparticles was about 53.15 ± 6.47 as
shown in Figure 1, which was consistent with other reports
(Bodna´r et al., 2005; Calvo et al., 1997). The polydispersity
index (PDI) value of chitosan nanoparticles was 0.287
indicating a narrow size distribution with favorable particle
size. When chitosan and TPP were mixed with each other,
they spontaneously formed compact nano complexes with an
overall positive surface charge. The density of the surface
charge is reflected by measured zeta (z) potential values, and
z-potential of prepared CNs were found to be 41.5 ± 1.8 mV
and positive due the presence of the protonated amine groups
on the chitosan backbone. The morphology and surface
appearance of chitosan nanoparticles were nearly spherical
shape, uniform and well dispersed as observed by AFM and
SEM (Figure 2(A,B) and Figure 3(A)). The size of chitosan
nanoparticles was also obtained via AFM in the range of
58–63 nm. The results were consistent with the measurement
of Zetasizer. The ability of the ionic gelation process to form
chitosan nanoparticles was assessed by employing FT-IR in
order to characterize and compare the functional groups of
chitosan and chitosan nanoparticles (data not shown). The
changes in functional group of chitosan nanoparticle were
consistent with our previous studies (_Ilgu¨ et al., 2011).
Therefore, we have concluded that the tripolyphosphoric
groups of TPP are linked with ammonium groups of chitosan
to form nanoparticles.
Figure 4. Schematic illustration of the chemical synthesis of BODIPY-COOH conjugated chitosan nanoparticles.
Figure 3. SEM images of (A) CNs at 1mm and (B) BODIPY-CNs at 3 mm scale.
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Carboxylated BODIPY was synthesized and purified
successfully using the method previously described with
some modifications (Brizet et al., 2013). The BODIPY-
COOH compound was characterized by classical spectro-
scopic analysis such as NMR spectroscopy and the final
product was obtained in 38% yield.
For synthesis of BODIPY-CNs, the reaction between the
chitosan nanoparticles and the BODIPY-COOH was allowed
to continue for 24 h on the magnetic stirrer at room
temperature. The presence of a large number of primary
amine and hydroxyl groups on the chitosan molecule gave a
possibility for many chemical interactions. In acidic pH,
amino groups of chitosan can undergo protonation and these
reactive groups of CNs on its polysaccharide chains could
make easier coupling reactions with BODIPY-COOH fluor-
ophore. The schematic mechanism of BODIPY-COOH and
CNs was illustrated in Figure 4. According to the mechanism,
BODIPY-COOH tends to make an interaction with the free
ammonium group (–NH2) of CNs due to the randomly coiled
arrangement form of particles with TPP at low pH during
ionic gelation process (Sijumon & Jose, 2010). The BODIPY-
COOH amount of the conjugated molecule was measured
by UV-visible Spectrophotometry at 510 nm and the bind-
ing efficiency (w/w %) of BODIPY-COOH to CNs was
calculated as 95%.
In the present study, the complexation of BODIPY-COOH
fluorophore and chitosan nanoparticles to form BODIPY-CNs
were characterized by physicochemical aspects by several
methods. The size distribution of BODIPY-CNs was similar
to CNs itself having a narrow batch with the mean size of
about 70.25 ± 11.99 nm. The particle size was slightly larger
than chitosan-TPP ones as expected, possibly due to the
addition of many BODIPY-COOH fluorophore to CNs.
The zeta potential of BODIPY-CNs nanoparticles reflect-
ing the particle surface charge density decreased to (+)
30.07 ± 2.6 mV because of reduced protonated amine groups
on the chitosan backbone. This simple relationship could be
easily explained as coupling reactions of reactive amino
groups of CNs with BODIPY-COOH fluorophore. The
interaction of CNs with BODIPY-COOH fluorophore could
also prevent possible aggregation of chitosan nanoparticles
and increase their stability. It was previously demonstrated
that the strong inter and intramolecular hydrogen bonding of
CNs could result in aggregation easily (Fan et al., 2012). The
carboxyl groups of the fluorophore may form many possible
interactions with –NH2 of CNs to eliminate nanoparticles
from aggregation. The morphology of BODIPY-CNs was
visualized by AFM and SEM as shown in Figures 2(C,D) and
3(B). The morphology and surface appearance of BODIPY-
CNs were similar to chitosan nanoparticles. Both AFM and
SEM images for BODIPY-CNs revealed a dense, well
dispersed and defined nearly spherical structure. The size of
BODIPY-CNs was measured by AFM images in the range of
70–78 nm, which was consistent with the particle size as
measured by DLS. The FT-IR studies of BODIPY-CNs were
also performed to characterize the changes in the chemical
structure of chitosan nanoparticles upon binding to the
Figure 6. (A) Fluorescence intensities of BODIPY-COOH conjugated chitosan nanoparticles and BODIPY-COOH. (B) Different concentration of
BODIPY-CNs (0.0, 0.05, 0.1, 0.2, 0.5 mg/ml right to left, respectively) under UV light.
Figure 5. FT-IR spectra of chitosan nanoparticles (CNs) and BODIPY-
COOH conjugated chitosan nanoparticles (BODIPY-CNs).
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fluorophore (Figure 5). In the spectrum of CNs, a band at
3436 cm1 indicates the combined peaks of the –NH2 and
–OH group stretching vibration. In the spectrum of BODIPY-
CNs, a shift from 3436 cm1 to 3440 cm1 was observed, and
the band is getting sharper which indicates the hydrogen
bonding enhancement. It has been also demonstrated that the
enhanced hydrogen bonding could lead to more compact
structure due to bonding of BODIPY-COOH to CNs (de
Pinho Neves et al., 2014; Qi et al., 2004). The band of CNs at
1642 cm1 corresponds to the CONH2 and –NH2 groups. This
peak shifted from 1642 cm1 to 1639 cm1 in the spectrum of
BODIPY-CNs, which shows that the ammonium groups make
an interaction with BODIPY-COOH. This finding also
confirms the proposed mechanism for the formation of
BODIPY-CNs. The peak at 1344 cm1 shifted to 1339 cm1
of BODIPY-CNs indicates the existence of CH3 groups. Both
CNs and BODIPY-CNs spectrum peaks at 1100 cm1 are
attributed to C–O stretching bands.
In the present study, fluorescence properties of BODIPY-
CNs were determined by fluorescence spectrophotometry
(Figure 6A). The results demonstrated that the fluorescent
intensity of the chitosan nanoparticles increased due to
BODIPY-COOH conjugation. The BODIPY-CNs solution in
different concentration exhibited a characteristic green
Figure 7. Cell viability of A549 and BEAS 2B cells after the treatment with CNs, BODIPY-CNs and BODIPY-COOH for 24 h, 48 h and 72 h. Each
value represents the mean ± SD (n¼ 6).
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fluorescence of BODIPY-COOH under UV light (Figure 6B).
Although 0.1 mg/ml CNs was in the first tube, it did not show
any fluorescence property, the same amount of BODIPY-CNs
reflected a considerable fluorescence intensity. As shown in
the third tube, 0.2 mg/ml BODIPY-CNs displayed a charac-
teristic green fluorescence color.
In vitro cell viability and imaging
The cytotoxicity of 0.5 mg/mL, 1 mg/mL, 2 mg/mL, 5 mg/mL,
10 mg/mL, 25 mg/mL and 50 mg/mL concentrations of the
BODIPY-CNs, CNs and BODIPY-COOH were investigated
on A549 cancer cells and BEAS 2B normal cells as control
using the MTT assay (Figure 7).
CNs itself did not show any significant toxic effect on both
cells types as expected because chitosan is a natural
biopolymer and known as biocompatible. Similar results
were obtained in other described reports for chitosan and
chitosan-related products (de Campos et al., 2004; Huang
et al., 2004). On the other hand, when BODIPY-COOH was
applied on A549 and BEAS 2B cells, cell viability decreased
with the raise in compound concentration as a concentration
dependent manner. After 24 h, BODIPY-COOH-treated cells
have 2% cell viability at 50 mg/ml compound concentration
for A549 and 10% for BEAS 2B cells. The present study
demonstrated that application of BODIPY-CNs on both cell
lines enhanced the cell viability up to 67% for A549 and 74%
for BEAS 2B cells. It was also observed that when the
incubation time increases up to 72 h, the cytotoxicity of both
BODIPY-COOH and BODIPY-CNs was decreased. This
finding shows that BODIPY-CNs acts similarly as CNs by
lowering cytotoxicity of BODIPY-COOH fluorophore.
Therefore, we can suggest that possible utilization of CNPs
together with BODIPY-COOH fluorophore could be a
good potential bioimaging agent in various applications
in medicine. This new proposed agent would not only
act as a fluorescent probe but also be nontoxic for the
applied cells.
In order to observe visually the location of BODIPY-CNs
in the cells, A549 cancer cells were treated with BODIPY-
CNs and blue fluorescent dye 40,6-diamidino-2-phenylindole
dihydrochloride (DAPI) and then measured by confocal laser
scanning microscopy. The present results in Figure 8 show
that BODIPY-CNs displayed strong localized fluorescence
within the cytoplasm of A549 cells as green color after 4 h of
incubation at 37 C. For the comparison of visual uptake of
BODIPY-COOH fluorophore and BODIPY-CNs in A549
cells, similar intense fluorescence signal were observed along
a layer on the cell cytoplasm and there was no apparent
difference in the fluorescence signal pattern of two com-
pounds treated cells. The cellular internalization and uptake
of both dye changed according to varied concentration of
BODIPY-CNs and BODIPY-COOH in a dose-dependent
manner (data is not shown). Similar results were reported
by other studies showing the uptake of the BODIPY-magnetic
nanocomposites increases with dose-dependent manner in
A549 and Ishikawa cells (Topel et al., 2015). By treatment of
cells with BODIPY-CNs, almost whole cells appeared in good
shape. Furthermore, similarly, A549 cells were stained with
DAPI for the uptake efficiency and localization profile. DAPI
as a marker to the nucleus showed blue fluorescence intensity
in the nuclei of A549 cells. The merged image reveals that
BODIPY-CNs could specifically bind to A549 cells and
localize in their cytoplasm.
Figure 8. Confocal images of A549 cells treated with 0.2 mg/mL of (A) BODIPY-CNs, (B) BODIPY-COOH after 4 h of incubation at 37 C.
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Conclusions
The present work aims to develop a new fluorescent
nanoparticle-based probe for various bioimaging applications
that can be used for medical interests. In the development of a
multifunctional fluorescent nano-size probe, first, CNs were
prepared based on ionic gelation method and BODIPY-
COOH fluorescent dye was synthesized as a type of organic
fluorescent molecule. Several methods were utilized to
determine the physicochemical properties of the CNs and
BODIPY-CNs. Cytotoxic effects of CNs, BODIPY-COOH
and BODIPY-CNs were evaluated comparing cell viability of
A549 and BEAS 2B cell lines. Confocal images confirmed
that the BODIPY-COOH-conjugated chitosan nanoparticles
could be utilized efficiently as a multifunctional fluorescent
probe. A major advantage of these conjugates is that they are
important promising tools for not only in advanced bioima-
ging systems, but also in intracellular drug delivery,
controlled drug release and ultra-sensitive molecular diagno-
sis events.
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